Equities researchers at StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research report issued on Saturday. The firm set a “hold” rating on the software maker’s stock.
Veradigm Price Performance
NASDAQ MDRX opened at $9.60 on Friday. The stock’s fifty day moving average is $9.49 and its two-hundred day moving average is $9.23. Veradigm has a fifty-two week low of $5.01 and a fifty-two week high of $13.22.
Institutional Trading of Veradigm
An institutional investor recently bought a new position in Veradigm stock. Innealta Capital LLC acquired a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Stock Dividend Cuts Happen Are You Ready?
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- How to Buy Cheap Stocks Step by Step
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
